| Model Number |
55-6070 |
| Medical Device Problem Code |
Loss of Osseointegration (2408)
|
| Health Effect - Clinical Codes |
Hypersensitivity/Allergic reaction (1907); Pain (1994); Inadequate Osseointegration (2646); No Code Available (3191)
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
(b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Event or Problem Description
|
|
The primary surgery was performed on (b)(6) 2007 via tha.It was reported that the revision surgery was performed on (b)(6) 2020 by removing pseudotumor tissue, washing out, and replacing the cup (manufactured by kyocera, p/n: 121780054, lot #: 00029) with 3 screws (p/n: unknown), the liner (p/n: 121887354), the head (p/n: 962710000) due to pain, loosening cup, pseudotumor.The surgery was completed, and it was unknown whether there was a surgical delay or not.No further information is available.
|
| |
|
Additional Manufacturer Narrative
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Product complaint #: (b)(4).Investigation summary: a worldwide complaint database search found no other reported incident(s) against the provided product/lot combination(s) since release for distribution.Based on previous investigations this complication of joint replacement is unlikely to have been the result of a device failing to meet required specifications.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Corrective action was not indicated.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Additional Manufacturer Narrative
|
|
Product complaint # (b)(4).Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report. h10 additional narrative: added: d10 .
|
| |
|
Search Alerts/Recalls
|